- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Sustainable Track Record
Global Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Jun 29, 2022
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
107 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VLSVita Life Sciences | AU$1.80 | 0% | 60.0% | AU$103.0m | n/a | PE12.4x | n/a | 3.3% | ||
| AFTAFT Pharmaceuticals | NZ$3.61 | -1.1% | -19.8% | NZ$378.6m | NZ$4.40 | PE19.1x | E13.0% | n/a | ||
| 601089Beijing Winsunny PharmaceuticalLTD | CNÂ¥21.05 | n/a | n/a | CNÂ¥10.1b | n/a | PE29.4x | n/a | n/a | ||
| 300896Imeik Technology DevelopmentLtd | CNÂ¥600.01 | 6.4% | -24.0% | CNÂ¥129.8b | CNÂ¥654.22 | PE121.7x | E37.8% | 0.3% | ||
| 688767Hangzhou Biotest BiotechLtd | CNÂ¥61.66 | -4.7% | n/a | CNÂ¥6.6b | n/a | PE6x | n/a | 4.9% | ||
| NOVNNovartis | CHF81.19 | 3.8% | -3.8% | CHF176.3b | CHF90.37 | PE7.6x | E2.7% | 3.6% | ||
| JNJJohnson & Johnson | US$176.99 | 0.7% | 7.4% | US$465.7b | US$187.28 | PE23.5x | E4.4% | 2.6% | ||
| MRKMerck | US$92.51 | 3.8% | 19.0% | US$233.9b | US$96.59 | PE16.8x | E11.8% | 3.0% | ||
| REGNRegeneron Pharmaceuticals | US$597.62 | 1.8% | 7.0% | US$64.4b | US$679.24 | PE8.1x | E-3.2% | n/a | ||
| SOHOSoho Global Health | Rp6,075.00 | 1.3% | 21.5% | Rp7.7t | n/a | PE13.7x | n/a | 3.2% | ||
| 500680Pfizer | ₹4,087.95 | -0.6% | -28.9% | ₹187.0b | ₹5,201.25 | PE30.5x | n/a | 0.9% | ||
| MEGAMega Lifesciences | ฿50.50 | 2.5% | 33.8% | ฿44.0b | ฿57.03 | PE19.8x | E6.6% | 2.7% | ||
| BETABeta Drugs | ₹709.35 | 16.2% | 114.5% | ₹6.8b | n/a | PE37.3x | n/a | n/a | ||
| GLAXOGlaxoSmithKline Pakistan | PK₨124.93 | 4.4% | -25.7% | PK₨39.8b | n/a | PE7.2x | n/a | 5.6% | ||
| 2395Shin Nippon Biomedical Laboratories | JPÂ¥1,978.00 | -1.8% | 122.5% | JPÂ¥82.3b | JPÂ¥3,300.00 | PE11.6x | E0.1% | 2.0% | ||
| CTECryosite | AU$0.63 | -3.1% | 61.5% | AU$30.8m | n/a | PE26.7x | n/a | 0% | ||
| AAgilent Technologies | US$117.90 | 3.6% | -20.2% | US$35.2b | US$149.13 | PE27.9x | E9.4% | 0.7% | ||
| 300653Yantai Zhenghai Biotechnology | CNÂ¥56.00 | -0.3% | 10.1% | CNÂ¥10.1b | n/a | PE56.1x | E25.1% | 1.0% | ||
| IBNSINAIBN SINA Pharmaceutical Industry | ৳296.70 | 4.3% | 20.3% | ৳9.3b | ৳370.00 | PE16.5x | S13.9% | 1.6% | ||
| GENOGenovis AB (publ.) | kr43.05 | -4.2% | -3.6% | kr2.9b | kr80.00 | PE77.4x | E55.6% | n/a | ||
| IPNIpsen | €90.05 | 4.1% | 1.9% | €7.4b | €102.50 | PE11.5x | E0.7% | 1.3% | ||
| 538837Jeevan Scientific Technology | ₹64.05 | 12.9% | -29.7% | ₹980.1m | n/a | PE6.5x | n/a | 0.8% | ||
| OCPHOctober PharmaE | ج.م159.95 | 0% | 68.3% | ج.م959.7m | n/a | PE8x | n/a | 1.9% | ||
| 915Shandong Shanda Wit Science and Technology | CNÂ¥41.35 | -0.2% | 53.7% | CNÂ¥9.7b | n/a | PE22.7x | E22.1% | 1.9% |